Lu-Ming Liu

686 total citations
21 papers, 548 citations indexed

About

Lu-Ming Liu is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Lu-Ming Liu has authored 21 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Lu-Ming Liu's work include Pancreatic and Hepatic Oncology Research (6 papers), TGF-β signaling in diseases (4 papers) and Cancer Mechanisms and Therapy (3 papers). Lu-Ming Liu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), TGF-β signaling in diseases (4 papers) and Cancer Mechanisms and Therapy (3 papers). Lu-Ming Liu collaborates with scholars based in China, United States and Hong Kong. Lu-Ming Liu's co-authors include Zhen Chen, Peng Wang, Song Gao, Zhi-Qiang Meng, Zhiqiang Meng, Yongqiang Hua, Hao Xi, Te Liu, Le Kuai and Jian-Min Luo and has published in prestigious journals such as PLoS ONE, International Journal of Radiation Oncology*Biology*Physics and Carcinogenesis.

In The Last Decade

Lu-Ming Liu

21 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu-Ming Liu China 14 315 184 178 62 50 21 548
Katharina John Germany 13 182 0.6× 102 0.6× 99 0.6× 17 0.3× 84 1.7× 20 533
Li Cai China 11 232 0.7× 82 0.4× 107 0.6× 17 0.3× 14 0.3× 21 483
Li Jing China 11 175 0.6× 160 0.9× 33 0.2× 19 0.3× 24 0.5× 28 339
Mo Ping China 7 192 0.6× 103 0.6× 73 0.4× 14 0.2× 14 0.3× 9 366
Libin Yang China 11 244 0.8× 161 0.9× 68 0.4× 12 0.2× 9 0.2× 29 460
Xuan Luo China 15 324 1.0× 170 0.9× 87 0.5× 7 0.1× 51 1.0× 24 608
Yuming Gu China 10 280 0.9× 202 1.1× 55 0.3× 9 0.1× 44 0.9× 33 453
Lin Xiao China 14 248 0.8× 134 0.7× 107 0.6× 8 0.1× 12 0.2× 57 513
Liyan Bai China 12 190 0.6× 73 0.4× 68 0.4× 9 0.1× 43 0.9× 30 365
Junming Xu China 12 239 0.8× 140 0.8× 97 0.5× 6 0.1× 20 0.4× 27 402

Countries citing papers authored by Lu-Ming Liu

Since Specialization
Citations

This map shows the geographic impact of Lu-Ming Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu-Ming Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu-Ming Liu more than expected).

Fields of papers citing papers by Lu-Ming Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu-Ming Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu-Ming Liu. The network helps show where Lu-Ming Liu may publish in the future.

Co-authorship network of co-authors of Lu-Ming Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Lu-Ming Liu. A scholar is included among the top collaborators of Lu-Ming Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu-Ming Liu. Lu-Ming Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Lu-Ming, Yulin Zhang, Shijun Wang, et al.. (2024). Decoding dynamic bamboo cell shrinkage with time-lapse microscopy and machine-learning. Industrial Crops and Products. 218. 118965–118965. 3 indexed citations
2.
Mo, Miao, et al.. (2019). A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cancer. Pancreatology. 19(2). 346–351. 19 indexed citations
3.
Gao, Song, et al.. (2017). Babaodan Capsule (八宝丹胶囊) combined with Qingyi Huaji Formula (清胰化积方) in advanced pancreatic cancer—a feasibility study. Chinese Journal of Integrative Medicine. 23(12). 937–942. 14 indexed citations
4.
Gao, Song, et al.. (2015). Establishment of a Pancreatic Cancer Stem Cell Model Using the SW1990 Human Pancreatic Cancer Cell Line in Nude Mice. Asian Pacific Journal of Cancer Prevention. 16(2). 437–442. 4 indexed citations
5.
Gao, Song, Peng Wang, Yongqiang Hua, et al.. (2015). ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Oncotarget. 7(2). 1608–1618. 107 indexed citations
6.
Gao, Song, Lianyu Chen, Peng Wang, Lu-Ming Liu, & Zhen Chen. (2014). MicroRNA Expression in Salivary Supernatant of Patients with Pancreatic Cancer and Its Relationship with ZHENG. BioMed Research International. 2014. 1–8. 31 indexed citations
8.
Liu, Lu-Ming, et al.. (2014). Huachansu injection inhibits metastasis of pancreatic cancer in mice model of human tumor xenograft. BMC Complementary and Alternative Medicine. 14(1). 483–483. 27 indexed citations
9.
Pan, Yan, et al.. (2013). The XRCC1 Arg399Gln Genetic Polymorphism Contributes to Hepatocellular Carcinoma Susceptibility: An Updated Meta-analysis. Asian Pacific Journal of Cancer Prevention. 14(10). 5761–5767. 5 indexed citations
10.
Liu, Lu-Ming, et al.. (2013). Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli. OncoTargets and Therapy. 6. 1129–1129. 49 indexed citations
11.
Chen, Hao, et al.. (2013). Electroacupuncture treatment for pancreatic cancer pain: A randomized controlled trial. Pancreatology. 13(6). 594–597. 54 indexed citations
12.
Chen, Zhen, Zhi-Qiang Meng, Jian-Min Luo, et al.. (2011). Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells. Biomedicine & Pharmacotherapy. 65(2). 123–131. 7 indexed citations
15.
Wang, Peng, Zhen Chen, Zhi-Qiang Meng, et al.. (2010). Ski Acts as Therapeutic Target of Qingyihuaji Formula in the Treatment of SW1990 Pancreatic Cancer. Integrative Cancer Therapies. 9(1). 50–58. 11 indexed citations
16.
Meng, Zhi-Qiang, et al.. (2009). Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis. Cancer Letters. 283(1). 84–91. 40 indexed citations
17.
Wang, Peng, Jie Fan, Zhen Chen, et al.. (2009). Low-Level Expression of Smad7 Correlates with Lymph Node Metastasis and Poor Prognosis in Patients with Pancreatic Cancer. Annals of Surgical Oncology. 16(4). 826–835. 37 indexed citations
18.
Wang, Peng, Zhen Chen, Zhi-Qiang Meng, et al.. (2009). Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function. Carcinogenesis. 30(9). 1497–1506. 47 indexed citations
19.
Liu, Lu-Ming. (2003). Establishment and development of clinical theory for integration of traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine. 1(4). 244–246. 2 indexed citations
20.
Liu, Lu-Ming, et al.. (1995). Effect of shenmai Injection on SIL-2R NK and LAK cells of patients with advanced carcinoma. Chinese Journal of Integrated Traditional and Western Medicine. 1(4). 255–257. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026